Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G9FL
|
|||
| Former ID |
DNCL003771
|
|||
| Drug Name |
CT-064
|
|||
| Synonyms |
Ibandronate sodium monohydrate; 138926-19-9; Ibandronate sodium hydrate; UNII-J12U072QL0; Ibandronate (Sodium Monohydrate); J12U072QL0; Bondenza; sodium hydrate hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate; Monosodium [1-hydroxy-3-(methylpentylamino)propane-1,1-diyl]diphosphonate monohydrate; Destara; Ibandronate sodium [USAN:JAN]; hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Osteoporosis [ICD-11: FB83.0; ICD-10: M85.8] | NDA filed | [1] | |
| Company |
Taisho Pharmaceutical; Chugai Pharmaceutical
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H24NNaO8P2
|
|||
| Canonical SMILES |
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]
|
|||
| InChI |
1S/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1
|
|||
| InChIKey |
VBDRTGFACFYFCT-UHFFFAOYSA-M
|
|||
| CAS Number |
CAS 138926-19-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
12014723, 16698272, 43042127, 47206334, 56039272, 57386953, 77278501, 91613939, 125432877, 126682005, 135246723, 152134091, 162177281, 163122789, 164227395, 172439446, 175267455, 175611050, 184545101, 186011329, 187072215, 204371131, 210279676, 210281999, 223392124, 223435664, 223658684, 227361372, 241034168, 249617131
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Chugai Pharmaceutical. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.